ChemicalBook Chinese Germany Japanese Korean

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

(+)-N-[(S)-α-(Chloromethyl)benzyl]acetamide
N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide
(+)-N-[(S)-2-Chloro-1-methylethyl]-N-methylformamide
(-)-N-[(S)-3-Chloro-1-methyl-2-oxopropyl]phthalimide
N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-methylmethanesulfonamide
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-ethylmethanesulfonamide
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}methanesulfonamide
N-(2-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}ethyl)methanesulfonamide
N-[[(1S)-11-Bromo-1,2,7,8,13,13bβ-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol]-1α-yl]-2-hydroxyacetamide 96426-93-6
N-[(1S)-2β-Bromocycloheptan-1α-yl]acetamide
(-)-N-[(S)-2-Bromohexanoyl]glycine
(-)-N-[(S)-2-Bromopropionyl]glycine
(+)-N-[(S)-α-(Bromomethyl)benzyl]acetamide
(-)-N-[(S)-3-Bromo-1-methyl-2-oxopropyl]phthalimide
Nα-[(2S)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan
(-)-N-[(S)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide
(-)-N-[(S)-2-Bromobutyryl]glycine
(-)-N-[(S)-2-Bromo-4-methylvaleryl]glycine
N-[(1S)-2β-Bromocyclopentan-1α-yl]acetamide
(-)-N-[(S)-2-Bromo-3-methylbutyryl]glycine
N-[(8α,9S)-cinchonan-9-yl]-3,5-bis(trifluoroMethyl)-BenzenesulfonaMide 1253690-78-6
N-(8α,9S)-cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylMethyl]-Thiourea 1222966-43-9
N-(8α,9S)-cinchonan-9-yl-N'-[(2S)-2-pyrrolidinylMethyl]-Thiourea 1222966-34-8
NSC632839hydrochloride 157654-67-6
NSC 23766 (hydrochloride) 1177865-17-6
NR-LU-10 antibody
(+)-N-[[(R)-N-Benzyloxycarbonyl-3-cyano-D-alanyl]oxy]succinimide
N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide 1005450-55-4
N-[(R)-1-(1-Naphtyl)ethyl]carbamic acid (E)-3-cyclohexylallyl ester
(-)-N-[(R)-2-(2-Naphtyl)propionyl]-4-morpholinecarbothioamide
(+)-N-[(R)-1-(1-Naphtyl)ethyl]formamide
N-[(R)-1-(1-NAPHTHYL)ETHYL]PHTHALAMIC ACID
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa14-30
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide (KLH)
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide
N-[(S)-Butan-2-yl]adenosine
N-[[(2S)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide
N-[3-[(S)-2-Butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]-N'-[3-[(S)-2-amino-4-guanidinobutyrylamino]propyl]butane-1,4-diamine
NSCL protein
N-[[(2S)-1-Decylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
N-(2-(S-coenzyme A)acetyl)spermidine 83889-68-3
NSC25872#NSC41835 116-44-9
N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine methyl ester
N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine
Nα-[(2R)-2-(Morpholinocarbonylmethyl)-3-(1-naphthalenyl)propionyl]-L-His-[(2R,3S)-3-amino*-2-hydroxy-5-methylhexanoic acid]isopropyl ester
Nα-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionyl]-L-histidine methyl ester
NRN1 (full length)
NSE
NQ Y15
N,S-DIACETYL-L-CYSTEINE METHYL ESTER 19547-88-7
N-[(1S)-4-(diaminomethylideneamino)-1-[(9-ethylcarbazol-3-yl)carbamoyl ]butyl]benzamide 82576-33-8
N,S-DIACETYLCYSTEAMINE 1420-88-8
N,S-DIACETYLCYSTEINE
3-N'-[(S)-3,6-Diaminohexanoyl]amphotericin B methyl ester
(+)-N-[(S)-4-Diazo-1-methyl-3-oxobutyl]phthalimide
(+)-N-[(S)-4-Diazo-2-methyl-3-oxobutyl]phthalimide
3-N'-[(S)-2,4-Diaminobutyryl]amphotericin B methyl ester
N-[(S)-1-(Diazoacetyl)-3-methylbutyl]-4-methylbenzenesulfonamide
N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]butane-1,4-diamine
N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-[4-hydroxy-3,5-di[(125I)iodo]phenyl]propanoylamino]propyl]butane-1,4-diamine
(+)-N-[(S)-5-Diazo-3-methyl-4-oxopentyl]phthalimide
(-)-N-[(S)-6-Diazo-3-methyl-5-oxohexyl]phthalimide
(-)-N-[(S)-1-(Diazoacetyl)butyl]phthalimide
(-)-N-[(S)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide
(-)-N-[(S)-1,2-Dicyclohexylethyl]maleimide
N-[(S)-1,2-Dicarboxyethyl]-D-glutamic acid 90245-73-1
(-)-N-[(S)-1,2-Di(cyclohexyl)ethyl]phthalimide
N-[2-[[(2S)-2α,6-Dicarboxy-1,2,3,4-tetrahydropyridin]-4-ylidene]ethylidene]glycine 135545-99-2
(-)-N-[(S)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide
N-[(S)-1-(2,4-DICHLOROPHENYL)ETHYL]-2-CYANO-3,3-DIMETHYLBUTANAMIDE
N,S-DI(2,4-DNP)-L-CYSTEINE 1655-62-5
(-)-N-[(S)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide
N-[(1S)-2,3-dihydro-1H-inden-1-yl]-1H-pyrrolo[2,3-d]pyriMidin-4-aMine 905580-86-1
N-[[(S)-2,3-Dihydro-1H-inden]-1β-yl]adenosine
N-[[(S)-2,3-Dihydro-5-methoxy-1H-inden]-1β-yl]adenosine
N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[[2-(trifluoroacetyl)propan-2-yl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
(+)-N-[(S)-3,β-Dihydroxyphenethyl]-N-methylacetamide
N-[[(S)-2,3-Dihydro-5-butoxy-1H-inden]-1β-yl]adenosine
(+)-N-[(S)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide
N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[(2-oxo-3,3,3-trifluoropropyl)carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
NSD2 (human recombinant)
N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine 230961-08-7
N-[(20S)-20-(Dimethylamino)-16β-hydroxy-4,4,14-trimethyl-11-oxo-9,19-cyclo-5α-pregnan-3β-yl]benzamide 15524-62-6
N-[(20S)-4,14-Dimethyl-20-(dimethylamino)-16β-hydroxy-4β-(hydroxymethyl)-9β,19-cyclo-5α-pregnan-3β-yl]benzamide 17934-60-0
N-[(5S,6β,7β,10α)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide
(-)-N-[(S)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide
N-[(2S)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
N-[[S,(+)]-2-(3,3-Dimethylpiperidino)-1-methylethyl]-N-(2-pyridyl)propionamide 24608-95-5
N-[(2S)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
(-)-N-[(S)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide
(+)-N-[(S)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide
N-[(20S)-20-(Dimethylamino)-16α-hydroxy-4α-(hydroxymethyl)-4,14-dimethyl-11-oxo-9β,19-cyclo-5α-pregnan-3β-yl]-2-methylpropanamide 4947-53-9
(+)-N-[(S)-1,2-Dimethylpropyl]-4-nitrobenzamide
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIMETHYLPROPANAMIDE
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIPHENYLACETAMIDE
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-(ETHYLTHIO)BENZAMIDE
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-NITROBENZAMIDE
N4-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine
2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560

Copyright 2007©  ChemicalBook. All rights reserved.